MEDIFAST INC Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2011 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Medifast Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2011 to Q1 2024.
- Medifast Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $112K, a 86% decline year-over-year.
- Medifast Inc annual Deferred Income Tax Expense (Benefit) for 2023 was $1.21M.
- Medifast Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$924K, a 75.1% increase from 2021.
- Medifast Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$3.72M, a 718% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)